Showing 16,981 - 17,000 results of 27,276 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 50 ((ng decrease) OR (mean decrease)) ))', query time: 1.10s Refine Results
  1. 16981

    SB-216763 inhibits the GSK-3 pathway. by Pramod K. Dash (246530)

    Published 2013
    “…<p><b>A</b>) Representative images of western blots for phospho-GSK-3ß, phospho-LRP6, phospho-ß-Catenin, phospho-Akt, and phospho-ERK in response to i.p. injection of SB-216763 (2.5 and 5.0 mg/kg) or vehicle (0 mg/kg) (n = 3/group). …”
  2. 16982
  3. 16983

    The thermo-mechanical response of PP nanocomposites at high graphene loading by Kai Yang (73590)

    Published 2016
    “…Small angle X-ray scattering (SAXS) showed a large decrease in the amount of lamellar structure relative to the neat PP, while wide angle X-ray scattering (WAXS) showed a high degree of crystallinity. …”
  4. 16984

    Evaluation of HLB epidemic progress in southern California vs survey data and the impact of quarantine radius to epidemic outcome. by Viet-Anh Nguyen (137745)

    Published 2023
    “…We show means of 1000 simulation realizations as solid lines, and 50%, 75%, 95% credible intervals as shades of decreasing intensities. …”
  5. 16985

    The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use by Ricardo Sobhie Diaz (154738)

    Published 2015
    “…NRTI acquired resistance was 86% in 2001–3 and decreased over time. NNRTI resistance increased from 2001-3(50%) to 2006–9 (60%), PI resistance decreased from 2001–3 (60%) to 2009 (40%), and 3-class resistance was stable over time around 25%. …”
  6. 16986

    Schematic of experimental paradigms. by Shiva Farashahi (5018381)

    Published 2018
    “…Following the appearance of the fixation cross and information about the maximum reward (50 and 100 points), subjects were presented with a diminishing arc informing them about the rate of reward decrease on a given trial. …”
  7. 16987

    Chronic administration of FT<sub>2</sub>Fc. by Anna Henzi (9635793)

    Published 2020
    “…<p>(a) Design of the prophylactic treatment experiment in ZH3 and WT mice. …”
  8. 16988
  9. 16989
  10. 16990
  11. 16991
  12. 16992

    Piroxicam and vehicle control do not impact canine UC cells <i>in vitro</i>. by Jordon M. Inkol (11237604)

    Published 2021
    “…<p>Representative IC50 curves for piroxicam treatment of AXA, Orig, and SH cells show no dose dependent decrease in cell viability up to 1mM (A). …”
  13. 16993

    Six-month outcomes of corneal crosslinking with dextran-free isotonic riboflavin solution by Refik Oltulu (5763947)

    Published 2018
    “…The mean spherical equivalent refraction decreased from -5.6 ± 2.4 diopters (D) preoperatively to -5.0 ± 2.1 D, and mean simulated keratometry decreased from 48.5 ± 2.5 D to 47.8 ± 2.6 D at 6 months. …”
  14. 16994

    DataSheet1_Lycium barbarum polysaccharide reverses drug resistance in oxaliplatin-resistant colon cancer cells by inhibiting PI3K/AKT-dependent phosphomannose isomerase.PDF by Lijun Ma (207865)

    Published 2024
    “…However, the spleen index decreased in the OXA and LBP + OXA groups (p < 0.05), possibly as a side effect of oxaliplatin. …”
  15. 16995

    dFmr1 regulates heart rate. by Stefanie Mares Novak (826953)

    Published 2015
    “…<b>(B)</b> Loss of dFmr1 (<i>dFmr1</i><sup><i>3/50M</i></sup>, N = 16) results in a statistically significant decrease in heart rate when compared to wild type (<i>w</i><sup><i>1118</i></sup>, N = 10). …”
  16. 16996
  17. 16997

    Loss of intestinal epithelial Shh signaling deregulates intestinal crypt epithelial proliferation. by Jessica Gagné-Sansfaçon (571087)

    Published 2014
    “…Proliferation assays were performed by PCNA immunostaining (G and H, green labeling), with Evans blue serving as counterstain (red staining). Mutants displayed a decrease in cell proliferation as shown by a decrease in the number of PCNA-labeled proliferating cells (H) when compared to controls (G). …”
  18. 16998

    Displacement of site marker ligands bound to HSA in presence of increasing PS concentrations. by Shevin R. Feroz (468333)

    Published 2013
    “…Spectra marked as ‘a’, ‘b’, ‘c’ and ‘d’ refer to 10 µM BR, 10 µM HSA, 50 µM PS and PS–HSA (5∶1) complex, respectively. …”
  19. 16999

    Data Sheet 1_Global respiratory tumor mortality correlation study with economic level, 2000–2019.docx by Mingjie Wang (1719895)

    Published 2025
    “…</p>Results<p>The core cohort included 50 countries with sufficient data. The global mean ASMR for respiratory cancers showed a decreasing trend from 2000 to 2019. …”
  20. 17000

    Effect of oral potassium supplementation on urinary potassium excretion and its diagnostic value for primary aldosteronism by Ke Zhang (115386)

    Published 2025
    “…</p> <p>The patients had a mean age of 49.38 years and 70% were male. Following a median potassium supplement dose of 8.50 g, serum potassium increased from 3.25 to 3.90 mmol/L (<i>p</i> < .001), and 24-hour urinary potassium (24 h UK) rose from 41.40 to 59.75 mmol/24 h (<i>p</i> = .004). …”